Correction to: Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations

被引：0
|
作者：
Dewang Angmo
Meenakshi Wadhwani
Thirumurthy Velpandian
Ankita Kotnala
Ramanjit Sihota
Tanuj Dada
机构：
[1] All India Institute of Medical Sciences,Glaucoma Research Facility and Clinical Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences
[2] All India Institute of Medical Sciences,Ocular Pharmacology, Dr Rajendra Prasad Centre for Ophthalmic Sciences
来源：
International Ophthalmology | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：363 / 363
相关论文
共 33 条
  • [1] Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
    Dewang Angmo
    Meenakshi Wadhwani
    Thirumurthy Velpandian
    Ankita Kotnala
    Ramanjit Sihota
    Tanuj Dada
    International Ophthalmology, 2017, 37 : 423 - 428
  • [2] Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
    Angmo, Dewang
    Wadhwani, Meenakshi
    Velpandian, Thirumurthy
    Kotnal, Ankita
    Sihota, Ramanjit
    Dada, Tanuj
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (02) : 423 - 428
  • [3] Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations (vol 37, pg 423, 2017)
    Angmo, Dewang
    Wadhwani, Meenakshi
    Velpandian, Thirumurthy
    Kotnala, Ankita
    Sihota, Ramanjit
    Dada, Tanuj
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (01) : 363 - 363
  • [4] Clinical efficacy of generic versus branded latanoprost for primary open angle glaucoma
    Kim, Diana H.
    Shaffer, Lames A.
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] EVALUATION OF SWITCHING BETWEEN BRANDED AND GENERIC LATANOPROST AFTER PATENT EXPIRATION IN THE NETHERLANDS
    Houweling, Leanne
    Woodruff, Seth
    Houben, Eline
    Liu, Larry
    Herings, Ron
    Subramaniam, Kannan
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 100 - 100
  • [6] Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
    Kim, Diana H.
    Addis, Victoria M.
    Pan, Wei
    VanderBeek, Brian L.
    OPHTHALMIC EPIDEMIOLOGY, 2019, 26 (01) : 63 - 71
  • [7] Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
    Zhao, Xiao-Ying
    Xu, Hui-Min
    Zhou, Quan
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 463 - 466
  • [8] The physical properties of generic latanoprost ophthalmic solutions are not identical
    Kolko, Miriam
    Jensen, Peter Koch
    ACTA OPHTHALMOLOGICA, 2017, 95 (04) : 370 - 373
  • [9] Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations Authors' reply
    Del Tacca, Mario
    Pasqualetti, Giuseppe
    Gori, Giovanni
    Pepe, Pasquale
    Di Paolo, Antonello
    Lastella, Marianna
    De Negri, Ferdinando
    Blandizzi, Corrado
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 467 - 468
  • [10] Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
    Del Tacca, Mario
    Pasqualetti, Giuseppe
    Gori, Giovanni
    Pepe, Pasquale
    Di Paolo, Antonello
    Lastella, Marianna
    De Negri, Ferdinando
    Blandizzi, Corrado
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 303 - 311
1234